{"nctId":"NCT00784134","briefTitle":"Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III","startDateStruct":{"date":"2009-07"},"conditions":["Intraventricular Hemorrhage"],"count":500,"armGroups":[{"label":"Alteplase","type":"EXPERIMENTAL","interventionNames":["Drug: Alteplase"]},{"label":"Saline Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Other: Normal saline"]}],"interventions":[{"name":"Alteplase","otherNames":["Cathflo Activase","rt-PA"]},{"name":"Normal saline","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Age 18-80\n* Symptom onset less than 24 hrs prior to diagnostic CT scan\n* Spontaneous ICH less than or equal to 30 cc or primary IVH\n* IVH obstructing 3rd and/or 4th ventricles\n* ICH clot stability at 6 hours or more post IVC placement\n* IVH clot stability at 6 hours or more post IVC placement\n* Catheter tract bleeding stability 6 hours or more post IVC placement\n* EVD placed per standard medical care\n* SBP less than 200 mmHg sustained for 6 hours prior to drug administration\n* Able to randomize within 72 hours of diagnostic CT scan\n* Historical Rankin of 0 or 1\n\nExclusion Criteria:\n\n* Suspected or untreated ruptured cerebral aneurysm, AVM, or tumor\n* Presence of a choroid plexus vascular malformation or Moyamoya\n* Clotting disorders\n* Platelet count less than 100,000, INR greater than 1.4\n* Pregnancy\n* Infratentorial hemorrhage\n* SAH at clinical presentation\n* ICH/IVH enlargement that cannot be stabilized in the treatment time window\n* Ongoing internal bleeding\n* Superficial or surface bleeding\n* Prior enrollment in the study\n* Any other condition that the investigator believes would pose a significant hazard to the subject if the investigational therapy were initiated\n* Planned or simultaneous participation (between screening and Day-30) in another interventional medical investigation or clinical trial.\n* No subject or legal representative to give written informed consent","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"80 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Participants With Modified Rankin Scale (mRS) <=3 - Dichotomized Analysis","description":"Analysis modified on September 29, 2015 to account for adaptive randomization. The modified Rankin Scale (mRS) is a commonly used scale for measuring the degree of disability or dependence in the daily activities of people who have suffered a stroke or other causes of neurological disability. It is scored from 0 (perfect health without symptoms) to 6 (death).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"47.6","spread":null},{"groupId":"OG001","value":"44.9","spread":null}]}]}]},{"type":"PRIMARY","title":"Participant Score on the Modified Rankin Scale (mRS) - Ordinal Analysis","description":"The modified Rankin Scale (mRS) is a commonly used scale for measuring the degree of disability or dependence in the daily activities of people who have suffered a stroke or other causes of neurological disability. It is scored from 0 (perfect health without symptoms) to 6 (death).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4","spread":null},{"groupId":"OG001","value":"4","spread":null}]}]}]},{"type":"PRIMARY","title":"Participants With Modified Rankin Scale (mRS) <=4 - Dichotomized Analysis","description":"The modified Rankin Scale (mRS) is a commonly used scale for measuring the degree of disability or dependence in the daily activities of people who have suffered a stroke or other causes of neurological disability. It is scored from 0 (perfect health without symptoms) to 6 (death).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"64.2","spread":null},{"groupId":"OG001","value":"61.6","spread":null}]}]}]},{"type":"PRIMARY","title":"Random Effects Assessment of Site Effect on Modified Rankin Scale (mRS) <= 3","description":"The modified Rankin Scale (mRS) is a commonly used scale for measuring the degree of disability or dependence in the daily activities of people who have suffered a stroke or other causes of neurological disability. It is scored from 0 (perfect health without symptoms) to 6 (death).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"47.6","spread":null},{"groupId":"OG001","value":"44.9","spread":null}]}]}]},{"type":"PRIMARY","title":"Longitudinal Assessment of Participants With Modified Rankin Scale (mRS) <=3","description":"Comparing longitudinal modified Rankin Scale (mRS) scores 0-3 at Day 30 and Day 180. The mRS is a commonly used scale for measuring the degree of disability or dependence in the daily activities of people who have suffered a stroke or other causes of neurological disability. It is scored from 0 (perfect health without symptoms) to 6 (death).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"20.4","spread":null},{"groupId":"OG001","value":"16.5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"48.0","spread":null},{"groupId":"OG001","value":"45.7","spread":null}]}]}]},{"type":"SECONDARY","title":"All Cause Mortality","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"18.5","spread":null},{"groupId":"OG001","value":"29.1","spread":null}]}]}]},{"type":"SECONDARY","title":"Clot Removal (Amount of Residual Blood)","description":"Change in blood volume measured between stability scan and end of treatment scan","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.96","spread":null},{"groupId":"OG001","value":"0.97","spread":null}]}]}]},{"type":"SECONDARY","title":"Intensity of Critical Care Management - Hospital Days","description":"Intensity of critical care management as measured by hospital and ICU length of stay, frequency of ICP \\>20 mmHg events, use of mechanical ventilation, pressors, and ventriculoperitioneal shunts, frequency of systemic infections.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"23","spread":null},{"groupId":"OG001","value":"24","spread":null}]}]}]},{"type":"SECONDARY","title":"Intensity of Critical Care Management - ICU Days","description":"Intensity of critical care management as measured by hospital and ICU length of stay, frequency of ICP \\>20 mmHg events, use of mechanical ventilation, pressors, and ventriculoperitioneal shunts, frequency of systemic infections.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"14","spread":null},{"groupId":"OG001","value":"15","spread":null}]}]}]},{"type":"SECONDARY","title":"Intensity of Critical Care Management - ICP Management","description":"Intensity of critical care management as measured by hospital and ICU length of stay, frequency of ICP \\>20 mmHg events, use of mechanical ventilation, pressors, and ventriculoperitioneal shunts, frequency of systemic infections.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"9.8","spread":null},{"groupId":"OG001","value":"10.2","spread":null}]}]}]},{"type":"SECONDARY","title":"Intensity of Critical Care Management - Mechanical Ventilation","description":"Intensity of critical care management as measured by hospital and ICU length of stay, frequency of ICP \\>20 mmHg events, use of mechanical ventilation, pressors, and ventriculoperitioneal shunts, frequency of systemic infections.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"73.9","spread":null},{"groupId":"OG001","value":"76.5","spread":null}]}]}]},{"type":"SECONDARY","title":"Intensity of Critical Care Management - Pressors","description":"Intensity of critical care management as measured by hospital and ICU length of stay, frequency of ICP \\>20 mmHg events, use of mechanical ventilation, pressors, and ventriculoperitioneal shunts, frequency of systemic infections.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"24.1","spread":null},{"groupId":"OG001","value":"25.1","spread":null}]}]}]},{"type":"SECONDARY","title":"Intensity of Critical Care Management - Shunts","description":"Intensity of critical care management as measured by hospital and ICU length of stay, frequency of ICP \\>20 mmHg events, use of mechanical ventilation, pressors, and ventriculoperitioneal shunts, frequency of systemic infections.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"18.5","spread":null},{"groupId":"OG001","value":"17.5","spread":null}]}]}]},{"type":"SECONDARY","title":"Intensity of Critical Care Management - All Infections","description":"Intensity of critical care management as measured by hospital and ICU length of stay, frequency of ICP \\>20 mmHg events, use of mechanical ventilation, pressors, and ventriculoperitioneal shunts, frequency of systemic infections.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"48.2","spread":null},{"groupId":"OG001","value":"50.6","spread":null}]}]}]},{"type":"SECONDARY","title":"Intensity of Critical Care Management - Pneumonia","description":"Intensity of critical care management as measured by hospital and ICU length of stay, frequency of ICP \\>20 mmHg events, use of mechanical ventilation, pressors, and ventriculoperitioneal shunts, frequency of systemic infections.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"26.1","spread":null},{"groupId":"OG001","value":"32.7","spread":null}]}]}]},{"type":"SECONDARY","title":"Intensity of Critical Care Management - All Infections","description":"Intensity of critical care management as measured by hospital and ICU length of stay, frequency of ICP \\>20 mmHg events, use of mechanical ventilation, pressors, and ventriculoperitioneal shunts, frequency of systemic infections.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"49.8","spread":null},{"groupId":"OG001","value":"56.2","spread":null}]}]}]},{"type":"SECONDARY","title":"Safety/Mortality - Mortality Within 30 Days","description":"Frequency of bacterial brain infections, symptomatic brain bleeds, and mortality.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"8.8","spread":null},{"groupId":"OG001","value":"14.3","spread":null}]}]}]},{"type":"SECONDARY","title":"Safety/Mortality - Bacterial Brain Infections Within 30 Days","description":"Frequency of bacterial brain infections, symptomatic brain bleeds, and mortality.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6.8","spread":null},{"groupId":"OG001","value":"10.4","spread":null}]}]}]},{"type":"SECONDARY","title":"Safety/Mortality - Systematic Bleeds Within 72 Hours","description":"Frequency of bacterial brain infections, symptomatic brain bleeds, and mortality.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.4","spread":null},{"groupId":"OG001","value":"2.0","spread":null}]}]}]},{"type":"SECONDARY","title":"Safety/Mortality - Systematic Bleeds Within 30 Days","description":"Frequency of bacterial brain infections, symptomatic brain bleeds, and mortality.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.6","spread":null},{"groupId":"OG001","value":"3.2","spread":null}]}]}]},{"type":"SECONDARY","title":"Adverse and Serious Adverse Events","description":"Assessment of number of adverse and serious adverse events by treatment group.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"45.8","spread":null},{"groupId":"OG001","value":"60.2","spread":null}]}]}]},{"type":"SECONDARY","title":"Predicting Hazards of Death by Treatment Group","description":"Cox Proportional Hazards Model is used to predict the hazards ratio by treatment group.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"18.5","spread":null},{"groupId":"OG001","value":"29.1","spread":null}]}]}]},{"type":"SECONDARY","title":"Sub-Group Analyses - Difference in Modified Rankin Scale (mRS) 0-3 Proportion by Race (African-American)","description":"Assessment of modified Rankin Scale (mRS) score 0-3 compared by race, gender, age, IVH size, and ICH location. The mRS is a commonly used scale for measuring the degree of disability or dependence in the daily activities of people who have suffered a stroke or other causes of neurological disability. It is scored from 0 (perfect health without symptoms) to 6 (death).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"54.4","spread":null},{"groupId":"OG001","value":"48.0","spread":null}]}]}]},{"type":"SECONDARY","title":"Sub-Group Analyses - Difference in Modified Rankin Scale (mRS) 0-3 Proportion by Race (White)","description":"Assessment of modified Rankin Scale (mRS) score 0-3 compared by race, gender, age, IVH size, and ICH location. The mRS is a commonly used scale for measuring the degree of disability or dependence in the daily activities of people who have suffered a stroke or other causes of neurological disability. It is scored from 0 (perfect health without symptoms) to 6 (death).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"43.4","spread":null},{"groupId":"OG001","value":"41.8","spread":null}]}]}]},{"type":"SECONDARY","title":"Sub-Group Analyses - Difference in Modified Rankin Scale (mRS) 0-3 Proportion by Gender (Female)","description":"Assessment of Modified Rankin Scale (mRS) score 0-3 compared by race, gender, age, IVH size, and ICH location. The mRS is a commonly used scale for measuring the degree of disability or dependence in the daily activities of people who have suffered a stroke or other causes of neurological disability. It is scored from 0 (perfect health without symptoms) to 6 (death).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"47.6","spread":null},{"groupId":"OG001","value":"45.6","spread":null}]}]}]},{"type":"SECONDARY","title":"Sub-Group Analyses - Difference in Modified Rankin Scale (mRS) 0-3 Proportion by Gender (Male)","description":"Assessment of Modified Rankin Scale (mRS) score 0-3 compared by race, gender, age, IVH size, and ICH location. The mRS is a commonly used scale for measuring the degree of disability or dependence in the daily activities of people who have suffered a stroke or other causes of neurological disability. It is scored from 0 (perfect health without symptoms) to 6 (death).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"47.6","spread":null},{"groupId":"OG001","value":"44.3","spread":null}]}]}]},{"type":"SECONDARY","title":"Sub-Group Analyses - Difference in Modified Rankin Scale (mRS) 0-3 Proportion by Age (65 Years or Under)","description":"Assessment of Modified Rankin Scale (mRS) score 0-3 compared by race, gender, age, IVH size, and ICH location. The mRS is a commonly used scale for measuring the degree of disability or dependence in the daily activities of people who have suffered a stroke or other causes of neurological disability. It is scored from 0 (perfect health without symptoms) to 6 (death).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"53.6","spread":null},{"groupId":"OG001","value":"52.1","spread":null}]}]}]},{"type":"SECONDARY","title":"Sub-Group Analyses - Difference in Modified Rankin Scale (mRS) 0-3 Proportion by Age (Over 65 Years)","description":"Assessment of Modified Rankin Scale (mRS) score 0-3 compared by race, gender, age, IVH size, and ICH location. The mRS is a commonly used scale for measuring the degree of disability or dependence in the daily activities of people who have suffered a stroke or other causes of neurological disability. It is scored from 0 (perfect health without symptoms) to 6 (death).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"31.3","spread":null},{"groupId":"OG001","value":"29.5","spread":null}]}]}]},{"type":"SECONDARY","title":"Sub-Group Analyses - Difference in Modified Rankin Scale (mRS) 0-3 Proportion by IVH Size (Less Than 20ml)","description":"Assessment of Modified Rankin Scale (mRS) score 0-3 compared by race, gender, age, IVH size, and ICH location. The mRS is a commonly used scale for measuring the degree of disability or dependence in the daily activities of people who have suffered a stroke or other causes of neurological disability. It is scored from 0 (perfect health without symptoms) to 6 (death).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"55.1","spread":null},{"groupId":"OG001","value":"58.3","spread":null}]}]}]},{"type":"SECONDARY","title":"Sub-Group Analyses - Difference in Modified Rankin Scale (mRS) 0-3 Proportion by IVH Size (20-50ml)","description":"Assessment of Modified Rankin Scale (mRS) score 0-3 compared by race, gender, age, IVH size, and ICH location. The mRS is a commonly used scale for measuring the degree of disability or dependence in the daily activities of people who have suffered a stroke or other causes of neurological disability. It is scored from 0 (perfect health without symptoms) to 6 (death).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"47.3","spread":null},{"groupId":"OG001","value":"38.5","spread":null}]}]}]},{"type":"SECONDARY","title":"Sub-Group Analyses - Difference in Modified Rankin Scale (mRS) 0-3 Proportion by IVH Size (Greater Than 50ml)","description":"Assessment of Modified Rankin Scale (mRS) score 0-3 compared by race, gender, age, IVH size, and ICH location. The mRS is a commonly used scale for measuring the degree of disability or dependence in the daily activities of people who have suffered a stroke or other causes of neurological disability. It is scored from 0 (perfect health without symptoms) to 6 (death).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"18.5","spread":null},{"groupId":"OG001","value":"17.9","spread":null}]}]}]},{"type":"SECONDARY","title":"Sub-Group Analyses - Difference in Modified Rankin Scale (mRS) 0-3 Proportion by Location (Thalamic)","description":"Assessment of Modified Rankin Scale (mRS) score 0-3 compared by race, gender, age, IVH size, and ICH location. The mRS is a commonly used scale for measuring the degree of disability or dependence in the daily activities of people who have suffered a stroke or other causes of neurological disability. It is scored from 0 (perfect health without symptoms) to 6 (death).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"38.8","spread":null},{"groupId":"OG001","value":"37.4","spread":null}]}]}]},{"type":"SECONDARY","title":"Sub-Group Analyses - Difference in Modified Rankin Scale (mRS) 0-3 Proportion by Location (Non-Thalamic)","description":"Assessment of Modified Rankin Scale (mRS) score 0-3 compared by race, gender, age, IVH size, and ICH location. The mRS is a commonly used scale for measuring the degree of disability or dependence in the daily activities of people who have suffered a stroke or other causes of neurological disability. It is scored from 0 (perfect health without symptoms) to 6 (death).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"60.6","spread":null},{"groupId":"OG001","value":"54.7","spread":null}]}]}]},{"type":"SECONDARY","title":"Functional Status - Barthel Index","description":"Assessment of NIHSS, Barthel Index, eGOS (dichotomy and ordinal) by group. The Barthel Index (BI) assesses ten functional tasks of daily living, and each task provides a measure for level of independence. Scores range from 0 and 100, with a higher score indicating greater independence.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"65.2","spread":"37.7"},{"groupId":"OG001","value":"69.5","spread":"35.1"}]}]}]},{"type":"SECONDARY","title":"Functional Status - Participants With Extended Glasgow Outcome (eGOS) Score >=Upper Severe Disability","description":"Assessment of NIHSS, Barthel Index, eGOS (dichotomy and ordinal) by group. The extended Glasgow Outcome Scale (eGOS) is a global scale for functional outcome with eight categories: 1 - Death, 2 - Vegetative State, 3 - Lower Severe Disability, 4 - Upper Severe Disability, 5 - Lower Moderate Disability, 6 - Upper Moderate Disability, 7 - Lower Good Recovery, 8 - Upper Good Recovery.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"95","spread":null},{"groupId":"OG001","value":"77","spread":null}]}]}]},{"type":"SECONDARY","title":"Functional Status - National Institutes of Health Stroke Scale (NIHSS)","description":"Assessment of NIHSS, Barthel Index, eGOS (dichotomy and ordinal) by group. The National Institutes of Health Stroke Scale (NIHSS) is a 15-item scale that assesses language, motor function, sensory loss, consciousness, visual fields, extraocular movements, coordination, neglect, and speech. It is scored from 0 (no stroke symptoms) to 42 (severe stroke).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3","spread":null},{"groupId":"OG001","value":"2","spread":null}]}]}]},{"type":"SECONDARY","title":"Quality of Life - Stroke Impact Scale (SIS) - Strength","description":"Assessment of SIS and EuroQol Visual Analog Scale by group. The Stroke Impact Scale (SIS) covers 8 dimensions of stroke outcomes: strength, hand function, activities of daily living/instrumental activities of daily living, mobility, communication, emotion, memory and thinking, participation. It is scored on a scale of 0 to 100 for each dimension, with higher scores indicating better self-reported health.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"54.97","spread":"35.37"},{"groupId":"OG001","value":"58.75","spread":"34.36"}]}]}]},{"type":"SECONDARY","title":"Quality of Life - Stroke Impact Scale (SIS) - Mobility","description":"Assessment of SIS and EuroQol Visual Analog Scale by group. The Stroke Impact Scale (SIS) covers 8 dimensions of stroke outcomes: strength, hand function, activities of daily living/instrumental activities of daily living, mobility, communication, emotion, memory and thinking, participation. It is scored on a scale of 0 to 100 for each dimension, with higher scores indicating better self-reported health.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"58.30","spread":"38.16"},{"groupId":"OG001","value":"60.10","spread":"36.05"}]}]}]},{"type":"SECONDARY","title":"Quality of Life - Stroke Impact Scale (SIS) - Hand Function","description":"Assessment of SIS and EuroQol Visual Analog Scale by group. The Stroke Impact Scale (SIS) covers 8 dimensions of stroke outcomes: strength, hand function, activities of daily living/instrumental activities of daily living, mobility, communication, emotion, memory and thinking, participation. It is scored on a scale of 0 to 100 for each dimension, with higher scores indicating better self-reported health.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"53.41","spread":"41.86"},{"groupId":"OG001","value":"56.52","spread":"39.69"}]}]}]},{"type":"SECONDARY","title":"Quality of Life - Stroke Impact Scale (SIS) - Activities of Daily Living","description":"Assessment of SIS and EuroQol Visual Analog Scale by group. The Stroke Impact Scale (SIS) covers 8 dimensions of stroke outcomes: strength, hand function, activities of daily living/instrumental activities of daily living, mobility, communication, emotion, memory and thinking, participation. It is scored on a scale of 0 to 100 for each dimension, with higher scores indicating better self-reported health.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"59.33","spread":"37.90"},{"groupId":"OG001","value":"61.19","spread":"34.98"}]}]}]},{"type":"SECONDARY","title":"Quality of Life - Stroke Impact Scale (SIS) - Communication","description":"Assessment of SIS and EuroQol Visual Analog Scale by group. The Stroke Impact Scale (SIS) covers 8 dimensions of stroke outcomes: strength, hand function, activities of daily living/instrumental activities of daily living, mobility, communication, emotion, memory and thinking, participation. It is scored on a scale of 0 to 100 for each dimension, with higher scores indicating better self-reported health.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"76.02","spread":"31.47"},{"groupId":"OG001","value":"79.60","spread":"26.76"}]}]}]},{"type":"SECONDARY","title":"Quality of Life - Stroke Impact Scale (SIS) - Thinking","description":"Assessment of SIS and EuroQol Visual Analog Scale by group. The Stroke Impact Scale (SIS) covers 8 dimensions of stroke outcomes: strength, hand function, activities of daily living/instrumental activities of daily living, mobility, communication, emotion, memory and thinking, participation. It is scored on a scale of 0 to 100 for each dimension, with higher scores indicating better self-reported health.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"58.48","spread":"33.11"},{"groupId":"OG001","value":"62.68","spread":"31.18"}]}]}]},{"type":"SECONDARY","title":"Quality of Life - Stroke Impact Scale (SIS) - Emotion","description":"Assessment of SIS and EuroQol Visual Analog Scale by group. The Stroke Impact Scale (SIS) covers 8 dimensions of stroke outcomes: strength, hand function, activities of daily living/instrumental activities of daily living, mobility, communication, emotion, memory and thinking, participation. It is scored on a scale of 0 to 100 for each dimension, with higher scores indicating better self-reported health.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"73.14","spread":"19.62"},{"groupId":"OG001","value":"73.45","spread":"20.24"}]}]}]},{"type":"SECONDARY","title":"Quality of Life - Stroke Impact Scale (SIS) - Participation","description":"Assessment of SIS and EuroQol Visual Analog Scale by group. The Stroke Impact Scale (SIS) covers 8 dimensions of stroke outcomes: strength, hand function, activities of daily living/instrumental activities of daily living, mobility, communication, emotion, memory and thinking, participation. It is scored on a scale of 0 to 100 for each dimension, with higher scores indicating better self-reported health.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"47.46","spread":"33.01"},{"groupId":"OG001","value":"49.58","spread":"33.03"}]}]}]},{"type":"SECONDARY","title":"Quality of Life - Stroke Impact Scale (SIS) - Recovery","description":"Assessment of SIS and EuroQol Visual Analog Scale by group. The Stroke Impact Scale (SIS) covers 8 dimensions of stroke outcomes: strength, hand function, activities of daily living/instrumental activities of daily living, mobility, communication, emotion, memory and thinking, participation. It is scored on a scale of 0 to 100 for each dimension, with higher scores indicating better self-reported health.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"60.04","spread":"26.42"},{"groupId":"OG001","value":"63.44","spread":"25.44"}]}]}]},{"type":"SECONDARY","title":"Quality of Life - EuroQol Visual Analogue Scale (EQ-VAS)","description":"Assessment of SIS and EuroQol Visual Analog Scale by group. EuroQol Visual Analogue Scale (EQ-VAS) is a self-reported measure of health status. It is a marked scale where individuals draw a line to indicate their health, with end points of 0 (the worst health you can imagine) and 100 (the best health you can imagine).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"62.8","spread":"26.0"},{"groupId":"OG001","value":"65.1","spread":"23.3"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":114,"n":249},"commonTop":["Fever","Pneumonia","Intracranial hypertension","Intracranial hemorrhage: Catheter Tract, New","Urinary tract infection"]}}}